Saturday, July 24, 2021

COVID vaccines risk reductions from the pre-emergency release short term testing

The absolute risk reductions 
for the current vaccines were tiny:
 
-- The relative risk reduction (RRR) 
 is best used for selling vaccines.

-- The absolute risk reduction (ARR)  
is meaningful for the general public.
 
Data below are for non-severe COVID symptoms.
RRR and ARR are both calculated with the same numbers.


Vaccine.............RRR...........ARR
Pfizer...............95%......... 0.84%
Moderna...........94%..........1.25%
Gamaleya..........91%......... 0.93%
John. & John.....67%..........1.2%
AstraZeneca ......67%..........1.3%

 

More details on Moderna and Pfizer:                                                                                      ................Placebo...Pfizer/BioNtech...ARR  
"Non-severe Covid"..0.88%.......0.044%........0.84%
"Severe Covid"........0.04%.......0.005%..........0.035% 
                                                                                                ..........................Placebo.....Moderna ........ARR 
 "Non-severe Covid"..1.33%..........0.08%.........1.25%
"Severe Covid"........0.22%............0%.............0.22%